- Home
- USAU vs SRZN Comparison
USAU vs SRZN Comparison
Compare USAU & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$15.01
HOLD
Current Price
$23.37
Company Overview
Basic Information| Metric | USAU | SRZN |
|---|---|---|
| Founded | 2014 | 2015 |
| Country | United States | United States |
| Employees | N/A | 44 |
| Industry | Precious Metals | Medicinal Chemicals and Botanical Products |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 266.0M | 271.6M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | USAU | SRZN |
|---|---|---|
| Price | $15.01 | $23.37 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $22.83 | ★ $38.00 |
| AVG Volume (30 Days) | ★ 261.4K | 152.8K |
| Earning Date | 03-16-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $17,402,000.00 | N/A |
| Revenue This Year | N/A | $75.35 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $10.09 | $8.21 |
| 52 Week High | $23.72 | $35.00 |
Technical Indicators
Market Signals| Indicator | USAU | SRZN |
|---|---|---|
| Relative Strength Index (RSI) | 46.00 | 43.50 |
| Support Level | $14.08 | $20.26 |
| Resistance Level | $16.39 | $24.50 |
| Average True Range (ATR) | 0.69 | 1.86 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 31.83 | 33.24 |
Price Performance
Historical Comparison USAU
SRZN
About USAU U.S. Gold Corp.
U.S. Gold Corp is an exploration and development company that owns certain mining leases and other mineral rights comprising the CK Gold Project in Wyoming, the Keystone Project in Nevada, and the Challis Gold Project in Idaho.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).